Chiralix 2015-试剂-金山科研平台

Chiralix 2015

2025-08-02

Chiralix 2015

金山科研平台代理微信：jinshanbioChiralix代理，Chiralix中国代理，Chiralix上海代理，Chiralix总代，ChiralixChiralix专业代理-金山科研平台，具体产品信息欢迎电询

Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集良好的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。

产品列表

货号	品名	化学名	CAS号	分子量	分子式	Synonyms	纯度	包装	价格	品牌
CX90418-1G	L-allysineethyleneacetal	(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid	215054-80-1	189.21	C8H15NO4	H-Aea-OH	99%	1G	6200	chiralix
CX90418-2G	L-allysineethyleneacetal	(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid	215054-80-1	189.21	C8H15NO4	H-Aea-OH	99%	2G	10600	chiralix
CX90418-5G	L-allysineethyleneacetal	(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoicacid	215054-80-1	189.21	C8H15NO4	H-Aea-OH	99%	5G	19900	chiralix
CX60325-200MG	D-homopropargylglycine	(R)-2-aminohex-5-ynoicacid	211054-02-3	127.14	C6H9NO2	H-D-Hpg-OH	>98%	200MG	4800	chiralix
CX60325-500MG	D-homopropargylglycine	(R)-2-aminohex-5-ynoicacid	211054-02-3	127.14	C6H9NO2	H-D-Hpg-OH	>98%	500MG	9800	chiralix
CX60325-1G	D-homopropargylglycine	(R)-2-aminohex-5-ynoicacid	211054-02-3	127.14	C6H9NO2	H-D-Hpg-OH	>98%	1G	16000	chiralix
CX80065-500MG	Fmoc-L-homopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	942518-21-0	349.38	C21H19NO4	Fmoc-Hpg-OH	>97%	500MG	11200	chiralix
CX80065-1G	Fmoc-L-homopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	942518-21-0	349.38	C21H19NO4	Fmoc-Hpg-OH	>97%	1G	18400	chiralix
CX90138-200MG	L-homopropargylglycine	(S)-2-aminohex-5-ynoicacid	98891-36-2	127.14	C6H9NO2	H-Hpg-OH	>98%	200MG	4800	chiralix
CX90138-500MG	L-homopropargylglycine	(S)-2-aminohex-5-ynoicacid	98891-36-2	127.14	C6H9NO2	H-Hpg-OH	>98%	500MG	9800	chiralix
CX90138-1G	L-homopropargylglycine	(S)-2-aminohex-5-ynoicacid	98891-36-2	127.14	C6H9NO2	H-Hpg-OH	>98%	1G	16000	chiralix
CX56292-500MG	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	108646-25-9	156.14	C7H8O4		>97%	500MG	6000	chiralix
CX56292-1G	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	(3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylicacid	108646-25-9	156.14	C7H8O4		>97%	1G	9800	chiralix
CX24022-500MG	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	38127-17-2	155.15	C7H9NO3		>98%	500MG	6000	chiralix
CX24022-1G	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylicacid	38127-17-2	155.15	C7H9NO3		>98%	1G	9800	chiralix
CX41399-1G	(S)-beta3-phenylalanine	(S)-3-amino-3-phenylpropanoicacid	40856-44-8	165.19	C9H11NO2		99%	1G	2200	chiralix
CX41399-2G	(S)-beta3-phenylalanine	(S)-3-amino-3-phenylpropanoicacid	40856-44-8	165.19	C9H11NO2		99%	2G	3800	chiralix
CX41399-5G	(S)-beta3-phenylalanine	(S)-3-amino-3-phenylpropanoicacid	40856-44-8	165.19	C9H11NO2		99%	5G	7200	chiralix
CX64691-1G	D-tert-leucine	(R)-2-amino-3,3-dimethylbutyricacid	26782-71-8	131.17	C6H13NO2	H-D-tert-Leu-OH	99%	1G	2200	chiralix
CX64691-2G	D-tert-leucine	(R)-2-amino-3,3-dimethylbutyricacid	26782-71-8	131.17	C6H13NO2	H-D-tert-Leu-OH	99%	2G	3800	chiralix
CX64691-5G	D-tert-leucine	(R)-2-amino-3,3-dimethylbutyricacid	26782-71-8	131.17	C6H13NO2	H-D-tert-Leu-OH	99%	5G	7200	chiralix
CX97471-500MG	(S)-alpha-methyl-phenylglycine	(S)-2-amino-2-phenylpropanoicacid	13398-26-0	165.19	C9H11NO2	(S)-H-Mpg-OH	>98%	500MG	5200	chiralix
CX97471-1G	(S)-alpha-methyl-phenylglycine	(S)-2-amino-2-phenylpropanoicacid	13398-26-0	165.19	C9H11NO2	(S)-H-Mpg-OH	>98%	1G	9000	chiralix
CX97471-2G	(S)-alpha-methyl-phenylglycine	(S)-2-amino-2-phenylpropanoicacid	13398-26-0	165.19	C9H11NO2	(S)-H-Mpg-OH	>98%	2G	14800	chiralix
CX58692-1G	(S)-allylglycinolhydrochloride	(S)-2-aminopent-4-en-1-olhydrochloride	926660-03-9	137.61	C5H12ClNO		>98%	1G	7400	chiralix
CX58692-2G	(S)-allylglycinolhydrochloride	(S)-2-aminopent-4-en-1-olhydrochloride	926660-03-9	137.61	C5H12ClNO		>98%	2G	12800	chiralix
CX40529-1G	(S)-propargylglycinolhydrochloride	(S)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	1G	8200	chiralix
CX40529-2G	(S)-propargylglycinolhydrochloride	(S)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	2G	14000	chiralix
CX80916-500MG	bis(N-Cbz)-2-deoxystreptamine	benzyl4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	6216-32-6	430.45	C22H26N2O7	bis-Z-2-DOS	>95%	500MG	6200	chiralix
CX80916-1G	bis(N-Cbz)-2-deoxystreptamine	benzyl4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	6216-32-6	430.45	C22H26N2O7	bis-Z-2-DOS	>95%	1G	10800	chiralix
CX93851-100MG	(2S,5R)-5-hydroxypipecolicacidhydrochloride	(2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride	824943-40-0	181.62	C6H12ClNO3		>98%	100MG	3800	chiralix
CX93851-500MG	(2S,5R)-5-hydroxypipecolicacidhydrochloride	(2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride	824943-40-0	181.62	C6H12ClNO3		>98%	500MG	12600	chiralix
CX93851-1G	(2S,5R)-5-hydroxypipecolicacidhydrochloride	(2S,5R)-5-hydroxypiperidine-2-carboxylicacidhydrochloride	824943-40-0	181.62	C6H12ClNO3		>98%	1G	19600	chiralix
CX19922-1G	(S)-beta3-phenylalaninemethylesterhydrochloride	(S)-methyl3-amino-3-phenylpropanoatehydrochloride	144494-72-4	215.68	C10H14ClNO2		>98%	1G	3000	chiralix
CX19922-2G	(S)-beta3-phenylalaninemethylesterhydrochloride	(S)-methyl3-amino-3-phenylpropanoatehydrochloride	144494-72-4	215.68	C10H14ClNO2		>98%	2G	5200	chiralix
CX19922-5G	(S)-beta3-phenylalaninemethylesterhydrochloride	(S)-methyl3-amino-3-phenylpropanoatehydrochloride	144494-72-4	215.68	C10H14ClNO2		>98%	5G	9800	chiralix
CX62577-10MG	6,8a-diepi-castanospermine	(1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol	106798-21-0	189.21	C8H15NO4		>98%	10MG	3600	chiralix
CX62577-50MG	6,8a-diepi-castanospermine	(1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol	106798-21-0	189.21	C8H15NO4		>98%	50MG	11800	chiralix
CX25404-1G	Fmoc-L-azidoornithine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoicacid	1097192-04-5	380.40	C20H20N4O4	Fmoc-Orn(N2)-OH	>98%	1G	3400	chiralix
CX25404-5G	Fmoc-L-azidoornithine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoicacid	1097192-04-5	380.40	C20H20N4O4	Fmoc-Orn(N2)-OH	>98%	5G	12000	chiralix
CX23880-5MG	rac-GR24	(3aR,8bS,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one	76974-79-3	298.29	C17H14O5		>98%	5MG	5000	chiralix
CX23880-20MG	rac-GR24	(3aR,8bS,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one	76974-79-3	298.29	C17H14O5		>98%	20MG	15000	chiralix
CX23880-100MG	rac-GR24	(3aR,8bS,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one	76974-79-3	298.29	C17H14O5		>98%	100MG	35000	chiralix
CX38605-1G	Fmoc-L-allysineethyleneacetal	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	411.45	C23H25NO6	Fmoc-Aea-OH	>97%	1G	7200	chiralix
CX38605-2G	Fmoc-L-allysineethyleneacetal	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	411.45	C23H25NO6	Fmoc-Aea-OH	>97%	2G	12400	chiralix
CX59650-1G	Fmoc-L-azidohomoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoicacid	942518-20-9	366.37	C19H18N4O4	Fmoc-Azh-OH	>98%	1G	3400	chiralix
CX59650-5G	Fmoc-L-azidohomoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoicacid	942518-20-9	366.37	C19H18N4O4	Fmoc-Azh-OH	>98%	5G	12000	chiralix
CX94894-200MG	L-bishomopropargylglycine	(S)-2-aminohept-6-ynoicacid	835627-45-7	141.17	C7H11NO2	H-Bpg-OH	>98%	200MG	4400	chiralix
CX94894-500MG	L-bishomopropargylglycine	(S)-2-aminohept-6-ynoicacid	835627-45-7	141.17	C7H11NO2	H-Bpg-OH	>98%	500MG	9000	chiralix
CX94894-1G	L-bishomopropargylglycine	(S)-2-aminohept-6-ynoicacid	835627-45-7	141.17	C7H11NO2	H-Bpg-OH	>98%	1G	14600	chiralix
CX13745-1G	(R)-propargylglycinolhydrochloride	(R)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	1G	8200	chiralix
CX13745-2G	(R)-propargylglycinolhydrochloride	(R)-2-aminopent-4-yn-1-olhydrochloride	Notavailable	135.59	C5H10ClNO		>98%	2G	14000	chiralix
CX78500-1G	(R)-allylglycinolhydrochloride	(R)-2-aminopent-4-en-1-olhydrochloride	926660-30-2	137.61	C5H12ClNO		>98%	1G	7400	chiralix
CX78500-2G	(R)-allylglycinolhydrochloride	(R)-2-aminopent-4-en-1-olhydrochloride	926660-30-2	137.61	C5H12ClNO		>98%	2G	12800	chiralix
CX69324-500MG	bis(N-Boc)-2-deoxystreptamine	tert-butyl(1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	189157-45-7	362.42	C16H30N2O7	bis-Boc-2-DOS	>95%	500MG	6200	chiralix
CX69324-1G	bis(N-Boc)-2-deoxystreptamine	tert-butyl(1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate	189157-45-7	362.42	C16H30N2O7	bis-Boc-2-DOS	>95%	1G	10800	chiralix
CX96388-1G	Boc-L-allysineethyleneacetal	(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	289.32	C13H23NO6	Boc-Aea-OH	>98%	1G	6200	chiralix
CX96388-2G	Boc-L-allysineethyleneacetal	(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	289.32	C13H23NO6	Boc-Aea-OH	>98%	2G	10600	chiralix
CX96388-5G	Boc-L-allysineethyleneacetal	(S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	Notavailable	289.32	C13H23NO6	Boc-Aea-OH	>98%	5G	19900	chiralix
CX42388-1G	Cbz-L-allysineethyleneacetal	(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	852822-01-6	323.34	C16H21NO6	Z-Aea-OH	>98%	1G	6200	chiralix
CX42388-2G	Cbz-L-allysineethyleneacetal	(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	852822-01-6	323.34	C16H21NO6	Z-Aea-OH	>98%	2G	10600	chiralix
CX42388-5G	Cbz-L-allysineethyleneacetal	(S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoicacid	852822-01-6	323.34	C16H21NO6	Z-Aea-OH	>98%	5G	19900	chiralix
CX44656-500MG	Boc-L-homopropargylglycine	(S)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	208522-16-1	227.26	C11H17NO4	Boc-Hpg-OH	>98%	500MG	9800	chiralix
CX44656-1G	Boc-L-homopropargylglycine	(S)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	208522-16-1	227.26	C11H17NO4	Boc-Hpg-OH	>98%	1G	16000	chiralix
CX69013-500MG	Cbz-L-homopropargylglycine	(S)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-Hpg-OH	>98%	500MG	9800	chiralix
CX69013-1G	Cbz-L-homopropargylglycine	(S)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-Hpg-OH	>98%	1G	16000	chiralix
CX54783-500MG	Boc-D-homopropargylglycine	(R)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	Notavailable	227.26	C11H17NO4	Boc-D-Hpg-OH	>98%	500MG	9800	chiralix
CX54783-1G	Boc-D-homopropargylglycine	(R)-2-(tert-butoxycarbonylamino)hex-5-ynoicacid	Notavailable	227.26	C11H17NO4	Boc-D-Hpg-OH	>98%	1G	16000	chiralix
CX14845-500MG	Cbz-D-homopropargylglycine	(R)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-D-Hpg-OH	>98%	500MG	9800	chiralix
CX14845-1G	Cbz-D-homopropargylglycine	(R)-2-(benzyloxycarbonylamino)hex-5-ynoicacid	Notavailable	261.27	C14H15NO4	Z-D-Hpg-OH	>98%	1G	16000	chiralix
CX87818-500MG	Fmoc-D-homopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	Notavailable	349.38	C21H19NO4	Fmoc-D-Hpg-OH	>97%	500MG	11200	chiralix
CX87818-1G	Fmoc-D-homopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoicacid	Notavailable	349.38	C21H19NO4	Fmoc-D-Hpg-OH	>97%	1G	18400	chiralix
CX57816-500MG	Fmoc-L-bishomopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-Bpg-OH	>97%	500MG	10400	chiralix
CX57816-1G	Fmoc-L-bishomopropargylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-Bpg-OH	>97%	1G	16800	chiralix
CX32424-200MG	D-bishomopropargylglycine	(R)-2-aminohept-6-ynoicacid	211054-03-4	141.17	C7H11NO2	H-D-Bpg-OH	>98%	200MG	4400	chiralix
CX32424-500MG	D-bishomopropargylglycine	(R)-2-aminohept-6-ynoicacid	211054-03-4	141.17	C7H11NO2	H-D-Bpg-OH	>98%	500MG	9000	chiralix
CX32424-1G	D-bishomopropargylglycine	(R)-2-aminohept-6-ynoicacid	211054-03-4	141.17	C7H11NO2	H-D-Bpg-OH	>98%	1G	14600	chiralix
CX80846-500MG	Fmoc-D-bishomopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-D-Bpg-OH	>97%	500MG	10400	chiralix
CX80846-1G	Fmoc-D-bishomopropargylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoicacid	Notavailable	363.41	C22H21NO4	Fmoc-D-Bpg-OH	>97%	1G	16800	chiralix
CX52977-1G	(S)-Boc-beta3-phenylalanine	(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid	103365-47-5	265.30	C14H19NO4		>98%	1G	2200	chiralix
CX52977-2G	(S)-Boc-beta3-phenylalanine	(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid	103365-47-5	265.30	C14H19NO4		>98%	2G	3800	chiralix
CX52977-5G	(S)-Boc-beta3-phenylalanine	(S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoicacid	103365-47-5	265.30	C14H19NO4		>98%	5G	7200	chiralix
CX79659-1G	(S)-Cbz-beta3-phenylalanine	(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid	14441-08-8	299.32	C17H17NO4		>98%	1G	2200	chiralix
CX79659-2G	(S)-Cbz-beta3-phenylalanine	(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid	14441-08-8	299.32	C17H17NO4		>98%	2G	3800	chiralix
CX79659-5G	(S)-Cbz-beta3-phenylalanine	(S)-3-(benzyloxycarbonylamino)-3-phenylpropanoicacid	14441-08-8	299.32	C17H17NO4		>98%	5G	7200	chiralix
CX56872-1G	(S)-Fmoc-beta3-phenylalanine	(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid	209252-15-3	387.43	C24H21NO4		>98%	1G	2600	chiralix
CX56872-2G	(S)-Fmoc-beta3-phenylalanine	(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid	209252-15-3	387.43	C24H21NO4		>98%	2G	4400	chiralix
CX56872-5G	(S)-Fmoc-beta3-phenylalanine	(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoicacid	209252-15-3	387.43	C24H21NO4		>98%	5G	8600	chiralix
CX44048-1G	Boc-D-tert-leucine	(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid	124655-17-0	231.29	C11H21NO4	Boc-D-tert-Leu-OH	>98%	1G	2200	chiralix
CX44048-2G	Boc-D-tert-leucine	(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid	124655-17-0	231.29	C11H21NO4	Boc-D-tert-Leu-OH	>98%	2G	3800	chiralix
CX44048-5G	Boc-D-tert-leucine	(R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoicacid	124655-17-0	231.29	C11H21NO4	Boc-D-tert-Leu-OH	>98%	5G	7200	chiralix
CX22855-1G	Fmoc-D-tert-leucine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid	198543-64-5	353.41	C21H23NO4	Fmoc-D-tert-Leu-OH	>97%	1G	2600	chiralix
CX22855-2G	Fmoc-D-tert-leucine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid	198543-64-5	353.41	C21H23NO4	Fmoc-D-tert-Leu-OH	>97%	2G	4400	chiralix
CX22855-5G	Fmoc-D-tert-leucine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoicacid	198543-64-5	353.41	C21H23NO4	Fmoc-D-tert-Leu-OH	>97%	5G	8600	chiralix
CX28901-1G	(S)-Boc-alpha-methyl-phenylglycine	(S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoicacid	802541-88-4	265.30	C14H19NO4	(S)-Boc-Mpg-OH	>98%	1G	9000	chiralix
CX28901-2G	(S)-Boc-alpha-methyl-phenylglycine	(S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoicacid	802541-88-4	265.30	C14H19NO4	(S)-Boc-Mpg-OH	>98%	2G	14800	chiralix
CX28344-1G	(S)-Fmoc-alpha-methyl-phenylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881921-11-5	387.43	C24H21NO4	(S)-Fmoc-Mpg-OH	>98%	1G	10400	chiralix
CX28344-2G	(S)-Fmoc-alpha-methyl-phenylglycine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881921-11-5	387.43	C24H21NO4	(S)-Fmoc-Mpg-OH	>98%	2G	17200	chiralix
CX93005-1G	Fmoc-L-azidoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoicacid	684270-46-0	352.34	C18H16N4O4	Fmoc-Aza-OH	>98%	1G	3400	chiralix
CX93005-5G	Fmoc-L-azidoalanine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoicacid	684270-46-0	352.34	C18H16N4O4	Fmoc-Aza-OH	>98%	5G	12000	chiralix
CX90286-200MG	bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine	4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate	90852-19-0	340.29	C12H16N6O6	2-DOSdiazidetriacetate	>98%	200MG	4200	chiralix
CX90286-500MG	bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine	4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate	90852-19-0	340.29	C12H16N6O6	2-DOSdiazidetriacetate	>98%	500MG	8800	chiralix
CX90286-1G	bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine	4t,6t-diazidocyclohexane-1r,2t,3c-triyltriacetate	90852-19-0	340.29	C12H16N6O6	2-DOSdiazidetriacetate	>98%	1G	15200	chiralix
CX44848-200MG	(R)-4-oxopipecolicacidethyleneacetal	(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	200MG	5200	chiralix
CX44848-500MG	(R)-4-oxopipecolicacidethyleneacetal	(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	500MG	11000	chiralix
CX44848-1G	(R)-4-oxopipecolicacidethyleneacetal	(R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	1G	19200	chiralix
CX45124-500MG	(R)-alpha-methyl-phenylglycine	(R)-2-amino-2-phenylpropanoicacid	29738-09-8	165.19	C9H11NO2	(R)-H-Mpg-OH	>98%	500MG	6200	chiralix
CX45124-1G	(R)-alpha-methyl-phenylglycine	(R)-2-amino-2-phenylpropanoicacid	29738-09-8	165.19	C9H11NO2	(R)-H-Mpg-OH	>98%	1G	10400	chiralix
CX45124-2G	(R)-alpha-methyl-phenylglycine	(R)-2-amino-2-phenylpropanoicacid	29738-09-8	165.19	C9H11NO2	(R)-H-Mpg-OH	>98%	2G	17200	chiralix
CX43844-1G	L-azidoleucineCHAsalt	cyclohexanaminium(S)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Leu-OH·CHA	>98%	1G	2800	chiralix
CX43844-5G	L-azidoleucineCHAsalt	cyclohexanaminium(S)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Leu-OH·CHA	>98%	5G	10600	chiralix
CX66793-1G	L-azidovalineCHAsalt	cyclohexanaminium(S)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-Val-OH·CHA	>98%	1G	2600	chiralix
CX66793-5G	L-azidovalineCHAsalt	cyclohexanaminium(S)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-Val-OH·CHA	>98%	5G	9800	chiralix
CX90285-1G	L-azidotryptophanCHAsalt	cyclohexanaminium(S)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-Trp-OH·CHA	>98%	1G	2400	chiralix
CX90285-5G	L-azidotryptophanCHAsalt	cyclohexanaminium(S)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-Trp-OH·CHA	>98%	5G	9000	chiralix
CX32182-1G	L-azidoalanineCHAsalt	cyclohexanaminium(S)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-Ala-OH·CHA	>98%	1G	2800	chiralix
CX32182-5G	L-azidoalanineCHAsalt	cyclohexanaminium(S)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-Ala-OH·CHA	>98%	5G	10600	chiralix
CX33085-1G	L-azidophenylalanineCHAsalt	cyclohexanaminium(S)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	N3-Phe-OH·CHA	>98%	1G	2400	chiralix
CX33085-5G	L-azidophenylalanineCHAsalt	cyclohexanaminium(S)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	N3-Phe-OH·CHA	>98%	5G	9000	chiralix
CX37236-1G	L-azidoisoleucineCHAsalt	cyclohexanaminium(2S,3S)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Ile-OH·CHA	>98%	1G	2800	chiralix
CX37236-5G	L-azidoisoleucineCHAsalt	cyclohexanaminium(2S,3S)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-Ile-OH·CHA	>98%	5G	10600	chiralix
CX81236-1G	L-azidotyrosineCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-Tyr-OH·CHA	>97%	1G	2800	chiralix
CX81236-5G	L-azidotyrosineCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-Tyr-OH·CHA	>97%	5G	10600	chiralix
CX84940-1G	L-azidomethionineCHAsalt	cyclohexanaminium(S)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-Met-OH·CHA	>98%	1G	2600	chiralix
CX84940-5G	L-azidomethionineCHAsalt	cyclohexanaminium(S)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-Met-OH·CHA	>98%	5G	9800	chiralix
CX81456-200MG	(S)-5-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	200MG	5200	chiralix
CX81456-500MG	(S)-5-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	500MG	11000	chiralix
CX81456-1G	(S)-5-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylicacid	Notavailable	187.19	C8H13NO4		>98%	1G	19200	chiralix
CX80632-1G	L-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-Thr(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX80632-5G	L-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-Thr(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX59871-1G	L-azidoserineCHAsalt	cyclohexanaminium(S)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-Ser-OH·CHA	>98%	1G	2600	chiralix
CX59871-5G	L-azidoserineCHAsalt	cyclohexanaminium(S)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-Ser-OH·CHA	>98%	5G	9800	chiralix
CX20625-1G	L-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-Asp(OtBu)-OH·CHA	>98%	1G	2600	chiralix
CX20625-5G	L-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-Asp(OtBu)-OH·CHA	>98%	5G	9800	chiralix
CX24163-1G	L-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-Glu(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX24163-5G	L-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(S)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-Glu(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX68680-1G	L-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-Tyr(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX68680-5G	L-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-Tyr(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX55921-1G	L-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-Ser(OtBu)-OH·CHA	>98%	1G	2800	chiralix
CX55921-5G	L-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(S)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-Ser(OtBu)-OH·CHA	>98%	5G	10600	chiralix
CX54776-200MG	(S)-4-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	356073-54-6	187.19	C8H13NO4		>98%	200MG	5200	chiralix
CX54776-500MG	(S)-4-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	356073-54-6	187.19	C8H13NO4		>98%	500MG	11000	chiralix
CX54776-1G	(S)-4-oxopipecolicacidethyleneacetal	(S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylicacid	356073-54-6	187.19	C8H13NO4		>98%	1G	19200	chiralix
CX46058-1G	D-azidovalineCHAsalt	cyclohexanaminium(R)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-D-Val-OH·CHA	>98%	1G	3000	chiralix
CX46058-5G	D-azidovalineCHAsalt	cyclohexanaminium(R)-2-azido-3-methylbutanoate	Notavailable	242.32	C11H22N4O2	N3-D-Val-OH·CHA	>98%	5G	11200	chiralix
CX44158-1G	D-azidoalanineCHAsalt	cyclohexanaminium(R)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-D-Ala-OH·CHA	>98%	1G	3400	chiralix
CX44158-5G	D-azidoalanineCHAsalt	cyclohexanaminium(R)-2-azidopropanoate	Notavailable	214.26	C9H18N4O2	N3-D-Ala-OH·CHA	>98%	5G	12800	chiralix
CX27954-1G	D-azidophenylalanineCHAsalt	cyclohexanaminium(R)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	D-N3-Phe-OH·CHA	>98%	1G	2800	chiralix
CX27954-5G	D-azidophenylalanineCHAsalt	cyclohexanaminium(R)-2-azido-3-phenylpropanoate	Notavailable	290.36	C15H22N4O2	D-N3-Phe-OH·CHA	>98%	5G	10600	chiralix
CX56656-1G	D-azidomethionineCHAsalt	cyclohexanaminium(R)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-D-Met-OH·CHA	>98%	1G	2800	chiralix
CX56656-5G	D-azidomethionineCHAsalt	cyclohexanaminium(R)-2-azido-4-(methylthio)butanoate	Notavailable	274.38	C11H22N4O2S	N3-D-Met-OH·CHA	>98%	5G	10600	chiralix
CX16129-500MG	Cbz-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX16129-1G	Cbz-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX65817-1G	(S)-Cbz-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate	Notavailable	398.50	C23H30N2O4	(S)-Cbz-Mpg-OH·CHA	>98%	1G	9000	chiralix
CX65817-2G	(S)-Cbz-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate	Notavailable	398.50	C23H30N2O4	(S)-Cbz-Mpg-OH·CHA	>98%	2G	14800	chiralix
CX19691-500MG	Boc-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-D-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX19691-1G	Boc-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-D-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX59796-500MG	Boc-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX59796-1G	Boc-L-bishomopropargylglycineCHAsalt	cyclohexanaminium(S)-2-(tert-butoxycarbonylamino)hept-6-ynoate	Notavailable	340.46	C18H32N2O4	Boc-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX79723-1G	(R)-Fmoc-alpha-methyl-phenylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881920-86-1	387.43	C24H21NO4	(R)-Fmoc-Mpg-OH	>98%	1G	12000	chiralix
CX79723-2G	(R)-Fmoc-alpha-methyl-phenylglycine	(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoicacid	881920-86-1	387.43	C24H21NO4	(R)-Fmoc-Mpg-OH	>98%	2G	19800	chiralix
CX32015-1G	Cbz-D-tert-leucineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate	Notavailable	364.48	C20H32N2O4	Z-D-tert-Leu-OH·CHA	>98%	1G	2200	chiralix
CX32015-2G	Cbz-D-tert-leucineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate	Notavailable	364.48	C20H32N2O4	Z-D-tert-Leu-OH·CHA	>98%	2G	3800	chiralix
CX32015-5G	Cbz-D-tert-leucineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate	Notavailable	364.48	C20H32N2O4	Z-D-tert-Leu-OH·CHA	>98%	5G	7200	chiralix
CX81118-1G	Fmoc-L-azidolysine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoicacid	159610-89-6	394.42	C21H22N4O4	Fmoc-Lys(N2)-OH	>98%	1G	3400	chiralix
CX81118-5G	Fmoc-L-azidolysine	(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoicacid	159610-89-6	394.42	C21H22N4O4	Fmoc-Lys(N2)-OH	>98%	5G	12000	chiralix
CX19587-500MG	Cbz-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-D-Bpg-OH·CHA	>98%	500MG	9000	chiralix
CX19587-1G	Cbz-D-bishomopropargylglycineCHAsalt	cyclohexanaminium(R)-2-(benzyloxycarbonylamino)hept-6-ynoate	Notavailable	374.47	C21H30N2O4	Z-D-Bpg-OH·CHA	>98%	1G	14600	chiralix
CX28021-500MG	H-Arg(Boc)2-pNA	(S,E)-tert-butyl(4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate	Notavailable	494.54	C22H34N6O7		>97%	500MG	6000	chiralix
CX28021-1G	H-Arg(Boc)2-pNA	(S,E)-tert-butyl(4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate	Notavailable	494.54	C22H34N6O7		>97%	1G	11000	chiralix
CX72798-1G	D-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-D-Asp(OtBu)-OH·CHA	>98%	1G	6200	chiralix
CX72798-5G	D-azidoasparticacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-4-tert-butoxy-4-oxobutanoate	Notavailable	314.38	C14H26N4O4	N3-D-Asp(OtBu)-OH·CHA	>98%	5G	23400	chiralix
CX93516-1G	D-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-D-Glu(OtBu)-OH·CHA	>98%	1G	5200	chiralix
CX93516-5G	D-azidoglutamicacidmono-tert-butylesterCHAsalt	cyclohexanaminium(R)-2-azido-5-tert-butoxy-5-oxopentanoate	Notavailable	328.41	C15H28N4O4	N3-D-Glu(OtBu)-OH·CHA	>98%	5G	19600	chiralix
CX76762-1G	D-azidoleucineCHAsalt	cyclohexanaminium(R)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Leu-OH·CHA	>98%	1G	3000	chiralix
CX76762-5G	D-azidoleucineCHAsalt	cyclohexanaminium(R)-2-azido-4-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Leu-OH·CHA	>98%	5G	11200	chiralix
CX53333-1G	D-azidoisoleucineCHAsalt	cyclohexanaminium(2R,3R)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Ile-OH·CHA	>98%	1G	9200	chiralix
CX53333-2G	D-azidoisoleucineCHAsalt	cyclohexanaminium(2R,3R)-2-azido-3-methylpentanoate	Notavailable	256.34	C12H24N4O2	N3-D-Ile-OH·CHA	>98%	2G	16400	chiralix
CX83245-1G	D-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-D-Tyr(OtBu)-OH·CHA	>98%	1G	5400	chiralix
CX83245-5G	D-azidotyrosinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-tert-butoxyphenyl)propanoate	Notavailable	362.47	C19H30N4O3	N3-D-Tyr(OtBu)-OH·CHA	>98%	5G	20400	chiralix
CX13425-1G	D-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-D-Ser(OtBu)-OH·CHA	>98%	1G	7200	chiralix
CX13425-5G	D-azidoserinetert-butyletherCHAsalt	cyclohexanaminium(R)-2-azido-3-tert-butoxypropanoate	Notavailable	286.37	C13H26N4O3	N3-D-Ser(OtBu)-OH·CHA	>98%	5G	27200	chiralix
CX29937-1G	D-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-D-Thr(OtBu)-OH·CHA	>98%	1G	6400	chiralix
CX29937-5G	D-azidothreoninetert-butyletherCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-tert-butoxybutanoate	Notavailable	300.40	C14H28N4O3	N3-D-Thr(OtBu)-OH·CHA	>98%	5G	24200	chiralix
CX85233-1G	L-azidothreonineCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-Thr-OH·CHA	>98%	1G	2600	chiralix
CX85233-5G	L-azidothreonineCHAsalt	cyclohexanaminium(2S,3R)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-Thr-OH·CHA	>98%	5G	9800	chiralix
CX37313-1G	D-azidothreonineCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-D-Thr-OH·CHA	>98%	1G	3000	chiralix
CX37313-5G	D-azidothreonineCHAsalt	cyclohexanaminium(2R,3S)-2-azido-3-hydroxybutanoate	Notavailable	244.29	C10H20N4O3	N3-D-Thr-OH·CHA	>98%	5G	11200	chiralix
CX95405-1G	D-azidoserineCHAsalt	cyclohexanaminium(R)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-D-Ser-OH·CHA	>98%	1G	3200	chiralix
CX95405-5G	D-azidoserineCHAsalt	cyclohexanaminium(R)-2-azido-3-hydroxypropanoate	Notavailable	230.26	C9H18N4O3	N3-D-Ser-OH·CHA	>98%	5G	12000	chiralix
CX57717-1G	L-azidoglutamineDCHAsalt	dicyclohexylammonium(S)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-Gln-OH·DCHA	>98%	1G	2600	chiralix
CX57717-5G	L-azidoglutamineDCHAsalt	dicyclohexylammonium(S)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-Gln-OH·DCHA	>98%	5G	9800	chiralix
CX79807-1G	D-azidoglutamineDCHAsalt	dicyclohexylammonium(R)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-D-Gln-OH·DCHA	>98%	1G	3200	chiralix
CX79807-5G	D-azidoglutamineDCHAsalt	dicyclohexylammonium(R)-5-amino-2-azido-5-oxopentanoate	Notavailable	353.46	C17H31N5O3	N3-D-Gln-OH·DCHA	>98%	5G	12000	chiralix
CX94556-1G	L-azidoasparagineDCHAsalt	dicyclohexylammonium(S)-4-amino-2-azido-4-oxobutanoate	79410-49-4	339.43	C16H29N5O3	N3-Asn-OH·DCHA	>98%	1G	3200	chiralix
CX94556-5G	L-azidoasparagineDCHAsalt	dicyclohexylammonium(S)-4-amino-2-azido-4-oxobutanoate	79410-49-4	339.43	C16H29N5O3	N3-Asn-OH·DCHA	>98%	5G	12000	chiralix
CX83100-1G	D-azidoasparagineDCHAsalt	dicyclohexylammonium(R)-4-amino-2-azido-4-oxobutanoate	Notavailable	339.43	C16H29N5O3	N3-D-Asn-OH·DCHA	>98%	1G	4000	chiralix
CX83100-5G	D-azidoasparagineDCHAsalt	dicyclohexylammonium(R)-4-amino-2-azido-4-oxobutanoate	Notavailable	339.43	C16H29N5O3	N3-D-Asn-OH·DCHA	>98%	5G	15000	chiralix
CX48141-1G	D-azidotryptophanCHAsalt	cyclohexanaminium(R)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-D-Trp-OH·CHA	>98%	1G	2600	chiralix
CX48141-5G	D-azidotryptophanCHAsalt	cyclohexanaminium(R)-2-azido-3-(1H-indol-2-yl)propanoate	Notavailable	329.40	C17H23N5O2	N3-D-Trp-OH·CHA	>98%	5G	9800	chiralix
CX93426-1G	N-im-trityl-L-azidohistidineCHAsalt	cyclohexanaminium(S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate	Notavailable	522.64	C31H34N6O2	N3-His(Trt)-OH·CHA	>98%	1G	4000	chiralix
CX93426-5G	N-im-trityl-L-azidohistidineCHAsalt	cyclohexanaminium(S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate	Notavailable	522.64	C31H34N6O2	N3-His(Trt)-OH·CHA	>98%	5G	15000	chiralix
CX24279-1G	D-azidotyrosineCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-D-Tyr-OH·CHA	>98%	1G	3600	chiralix
CX24279-5G	D-azidotyrosineCHAsalt	cyclohexanaminium(R)-2-azido-3-(4-hydroxyphenyl)propanoate	Notavailable	306.36	C15H22N4O3	N3-D-Tyr-OH·CHA	>98%	5G	13600	chiralix
CX78063-1G	L-azido-tert-leucineCHAsalt	cyclohexanaminium(S)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-tert-Leu-OH·CHA	>98%	1G	2800	chiralix
CX78063-5G	L-azido-tert-leucineCHAsalt	cyclohexanaminium(S)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-tert-Leu-OH·CHA	>98%	5G	10600	chiralix
CX30547-1G	D-azido-tert-leucineCHAsalt	cyclohexanaminium(R)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-D-tert-Leu-OH·CHA	>98%	1G	6600	chiralix
CX30547-5G	D-azido-tert-leucineCHAsalt	cyclohexanaminium(R)-2-azido-3,3-dimethylbutanoate	Notavailable	256.34	C12H24N4O2	N3-D-tert-Leu-OH·CHA	>98%	5G	25000	chiralix
CX78942-1G	L-azidoallylglycineCHAsalt	cyclohexanaminium(S)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-Alg-OH·CHA	>98%	1G	5600	chiralix
CX78942-5G	L-azidoallylglycineCHAsalt	cyclohexanaminium(S)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-Alg-OH·CHA	>98%	5G	21200	chiralix
CX61332-1G	D-azidoallylglycineCHAsalt	cyclohexanaminium(R)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-D-Alg-OH·CHA	>98%	1G	9000	chiralix
CX61332-2G	D-azidoallylglycineCHAsalt	cyclohexanaminium(R)-2-azidopent-4-enoate	Notavailable	240.30	C11H20N4O2	N3-D-Alg-OH·CHA	>98%	2G	16000	chiralix
CX56925-1G	Ng-Pmc-L-azidoarginine	(S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoicacid	Notavailable	466.55	C20H30N6O5S	Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine	>95%	1G	4000	chiralix
CX56925-5G	Ng-Pmc-L-azidoarginine	(S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoicacid	Notavailable	466.55	C20H30N6O5S	Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine	>95%	5G	15000	chiralix
CX22361-1G	(S)-azido-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(S)-N3-Mpg-OH·CHA	>98%	1G	9000	chiralix
CX22361-2G	(S)-azido-alpha-methyl-phenylglycineCHAsalt	cyclohexanaminium(S)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(S)-N3-Mpg-OH·CHA	>98%	2G	14800	chiralix
CX52265-1G	(R)-azido-alpha-methylphenylglycineCHAsalt	cyclohexanaminium(R)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(R)-N3-Mpg-OH·CHA	>98%	1G	10400	chiralix
CX52265-2G	(R)-azido-alpha-methylphenylglycineCHAsalt	cyclohexanaminium(R)-2-azido-2-phenylpropanoate	Notavailable	290.36	C15H22N4O2	(R)-N3-Mpg-OH·CHA	>98%	2G	17200	chiralix
CX71813-1G	S-Trityl-L-azidocysteineCHAsalt	cyclohexanaminium(R)-2-azido-3-(tritylthio)propanoate	Notavailable	488.64	C28H32N4O2S	N3-Cys(Trt)-OH·CHA	>98%	1G	3000	chiralix
CX71813-5G	S-Trityl-L-azidocysteineCHAsalt	cyclohexanaminium(R)-2-azido-3-(tritylthio)propanoate	Notavailable	488.64	C28H32N4O2S	N3-Cys(Trt)-OH·CHA	>98%	5G	11200	chiralix
CX40608-5G	6-azidohexanoicacid	6-azidohexanoicacid	79598-53-1	157.17	C6H11N3O2		>98%	5G	6000	chiralix
CX40608-10G	6-azidohexanoicacid	6-azidohexanoicacid	79598-53-1	157.17	C6H11N3O2		>98%	10G	11000	chiralix
CX23053-500MG	(S)-bishomopropargylglycinolhydrochloride	(S)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	500MG	10400	chiralix
CX23053-1G	(S)-bishomopropargylglycinolhydrochloride	(S)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	1G	17200	chiralix
CX63523-500MG	(R)-bishomopropargylglycinolhydrochloride	(R)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	500MG	10400	chiralix
CX63523-1G	(R)-bishomopropargylglycinolhydrochloride	(R)-2-aminohept-6-yn-1-olhydrochloride	Notavailable	163.65	C7H14ClNO		>98%	1G	17200	chiralix
CX69091-500MG	(R)-homopropargylglycinolhydrochloride	(R)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	500MG	11000	chiralix
CX69091-1G	(R)-homopropargylglycinolhydrochloride	(R)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	1G	17800	chiralix
CX76358-500MG	(S)-homopropargylglycinolhydrochloride	(S)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	500MG	11000	chiralix
CX76358-1G	(S)-homopropargylglycinolhydrochloride	(S)-2-aminohex-5-yn-1-olhydrochloride	Notavailable	149.62	C6H12ClNO		>98%	1G	17800	chiralix
CX55029-2MG	cereulide	cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3	Notavailable	1153.40	C57H96N6O18		>95%	2MG	12000	chiralix
CX55029-5MG	cereulide	cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3	Notavailable	1153.40	C57H96N6O18		>95%	5MG	24000	chiralix
CX45120-1G	H-Orn(Boc)-pNA	(S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate	Notavailable	352.39	C16H24N4O5		>98%	1G	4000	chiralix
CX45120-2G	H-Orn(Boc)-pNA	(S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate	Notavailable	352.39	C16H24N4O5		>98%	2G	9000	chiralix
CX45120-5G	H-Orn(Boc)-pNA	(S)-tert-butyl(4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate	Notavailable	352.39	C16H24N4O5		>98%	5G	15000	chiralix
CX57163-2MG	13C6-cereulide	cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3	Notavailable	1159.36	C5113C6H96N6O18		>95%	2MG	24000	chiralix
CX64158-1G	Fmoc-Orn-pNA·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	510.97	C26H27ClN4O5	Fmoc-Orn-pNAHClsalt	>98%	1G	4000	chiralix
CX64158-2G	Fmoc-Orn-pNA·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	510.97	C26H27ClN4O5	Fmoc-Orn-pNAHClsalt	>98%	2G	7200	chiralix
CX64158-5G	Fmoc-Orn-pNA·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	510.97	C26H27ClN4O5	Fmoc-Orn-pNAHClsalt	>98%	5G	15000	chiralix
CX80044-250MG	Bis(H-Orn(Boc))-rhodamine110	Bis(H-Orn(Boc))-rhodamine	Notavailable	758.86	C40H50N6O9		>95%	250MG	7600	chiralix
CX80044-500MG	Bis(H-Orn(Boc))-rhodamine110	Bis(H-Orn(Boc))-rhodamine	Notavailable	758.86	C40H50N6O9		>95%	500MG	14000	chiralix
CX80044-1G	Bis(H-Orn(Boc))-rhodamine110	Bis(H-Orn(Boc))-rhodamine	Notavailable	758.86	C40H50N6O9		>95%	1G	25000	chiralix
CX67830-250MG	Bis(H-Arg(Boc)2)-rhodamine110	Bis(H-Arg(Boc)2)-rhodamine	Notavailable	1043.17	C52H70N10O13		>95%	250MG	7800	chiralix
CX67830-500MG	Bis(H-Arg(Boc)2)-rhodamine110	Bis(H-Arg(Boc)2)-rhodamine	Notavailable	1043.17	C52H70N10O13		>95%	500MG	14400	chiralix
CX67830-1G	Bis(H-Arg(Boc)2)-rhodamine110	Bis(H-Arg(Boc)2)-rhodamine	Notavailable	1043.17	C52H70N10O13		>95%	1G	26000	chiralix
CX18326-1G	Fmoc-Orn-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	548.03	C30H30ClN3O5		>98%	1G	5000	chiralix
CX18326-2G	Fmoc-Orn-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	548.03	C30H30ClN3O5		>98%	2G	9000	chiralix
CX18326-5G	Fmoc-Orn-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamatehydrochloride	Notavailable	548.03	C30H30ClN3O5		>98%	5G	19000	chiralix
CX59077-1G	H-Orn(Boc)-AMC	(S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate	Notavailable	389.45	C20H27N3O5		>98%	1G	6000	chiralix
CX59077-2G	H-Orn(Boc)-AMC	(S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate	Notavailable	389.45	C20H27N3O5		>98%	2G	10800	chiralix
CX59077-5G	H-Orn(Boc)-AMC	(S)-tert-butyl(4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate	Notavailable	389.45	C20H27N3O5		>98%	5G	22000	chiralix
CX48623-1G	H-Lys(Boc)-AMC	(S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate	222037-62-9	403.47	C21H29N3O5		>98%	1G	5000	chiralix
CX48623-2G	H-Lys(Boc)-AMC	(S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate	222037-62-9	403.47	C21H29N3O5		>98%	2G	9000	chiralix
CX48623-5G	H-Lys(Boc)-AMC	(S)-tert-butyl(5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate	222037-62-9	403.47	C21H29N3O5		>98%	5G	19000	chiralix
CX55361-500MG	H-Arg(Boc)2-AMC	H-Arg(Boc)2-AMC	Notavailable	531.60	C26H37N5O7		>97%	500MG	6000	chiralix
CX55361-1G	H-Arg(Boc)2-AMC	H-Arg(Boc)2-AMC	Notavailable	531.60	C26H37N5O7		>97%	1G	10800	chiralix
CX84944-1G	Fmoc-Lys-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride	Notavailable	562.06	C31H32ClN3O5		>98%	1G	4000	chiralix
CX84944-2G	Fmoc-Lys-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride	Notavailable	562.06	C31H32ClN3O5		>98%	2G	7200	chiralix
CX84944-5G	Fmoc-Lys-AMC·HCl	(S)-(9H-fluoren-9-yl)methyl(6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamatehydrochloride	Notavailable	562.06	C31H32ClN3O5		>98%	5G	15000	chiralix
CX69359-5G	4-azidobutyricacid	4-azidobutanoicacid	54447-68-6	129.12	C4H7N3O2	gamma-azidobutyricacid	>98%	5G	6000	chiralix
CX69359-10G	4-azidobutyricacid	4-azidobutanoicacid	54447-68-6	129.12	C4H7N3O2	gamma-azidobutyricacid	>98%	10G	11000	chiralix
CX31309-5G	5-azidovalericacid	5-azidopentanoicacid	79583-98-5	143.14	C5H9N3O2	delta-azidovalericacid	>98%	5G	6600	chiralix
CX31309-10G	5-azidovalericacid	5-azidopentanoicacid	79583-98-5	143.14	C5H9N3O2	delta-azidovalericacid	>98%	10G	11800	chiralix
CX98490-5G	7-azidoheptanoicacid	7-azidoheptanoicacid	135920-28-4	171.20	C7H13N3O2		>98%	5G	6000	chiralix
CX98490-10G	7-azidoheptanoicacid	7-azidoheptanoicacid	135920-28-4	171.20	C7H13N3O2		>98%	10G	11000	chiralix
CX65527-1G	6-methylcyclohex-1-enecarboxylicacid	6-methylcyclohex-1-enecarboxylicacid	5726-56-7	140.18	C8H12O2		>98%	1G	2800	chiralix
CX65527-5G	6-methylcyclohex-1-enecarboxylicacid	6-methylcyclohex-1-enecarboxylicacid	5726-56-7	140.18	C8H12O2		>98%	5G	10600	chiralix
CX65527-10G	6-methylcyclohex-1-enecarboxylicacid	6-methylcyclohex-1-enecarboxylicacid	5726-56-7	140.18	C8H12O2		>98%	10G	17000	chiralix
CX61074-200MG	(S)-beta2-homoalanineHClsalt	(S)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(S)-beta2-hAla-OH·HCl	>98%	200MG	4800	chiralix
CX61074-500MG	(S)-beta2-homoalanineHClsalt	(S)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(S)-beta2-hAla-OH·HCl	>98%	500MG	9800	chiralix
CX61074-1G	(S)-beta2-homoalanineHClsalt	(S)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(S)-beta2-hAla-OH·HCl	>98%	1G	16000	chiralix
CX39389-200MG	(R)-beta2-homoalanineHClsalt	(R)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(R)-beta2-hAla-OH·HCl	>98%	200MG	4800	chiralix
CX39389-500MG	(R)-beta2-homoalanineHClsalt	(R)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(R)-beta2-hAla-OH·HCl	>98%	500MG	9800	chiralix
CX39389-1G	(R)-beta2-homoalanineHClsalt	(R)-3-amino-2-methylpropanoicacidhydrochloride	Notavailable	139.58	C4H10ClNO2	(R)-beta2-hAla-OH·HCl	>98%	1G	16000	chiralix
CX80391-200MG	(R)-beta2-homoleucineHClsalt	(R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(R)-beta2-hLeu-OH·HCl	>98%	200MG	4800	chiralix
CX80391-500MG	(R)-beta2-homoleucineHClsalt	(R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(R)-beta2-hLeu-OH·HCl	>98%	500MG	9800	chiralix
CX80391-1G	(R)-beta2-homoleucineHClsalt	(R)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(R)-beta2-hLeu-OH·HCl	>98%	1G	16000	chiralix
CX82876-200MG	(R)-beta2-homovalineHClsalt	(R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(R)-beta2-hVal-OH·HCl	>98%	200MG	4800	chiralix
CX82876-500MG	(R)-beta2-homovalineHClsalt	(R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(R)-beta2-hVal-OH·HCl	>98%	500MG	9800	chiralix
CX82876-1G	(R)-beta2-homovalineHClsalt	(R)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(R)-beta2-hVal-OH·HCl	>98%	1G	16000	chiralix
CX93488-1MG	(±)-sorgolactone	(3aR,8S,8bS,2'R)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	Notavailable	316.35	C18H20O5	racemicsorgolactone	>98%	1MG	4000	chiralix
CX93488-5MG	(±)-sorgolactone	(3aR,8S,8bS,2'R)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	Notavailable	316.35	C18H20O5	racemicsorgolactone	>98%	5MG	15000	chiralix
CX64382-1MG	(±)-strigol	(3aR,5S,8bS,2'R)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	51820-11-2	346.37	C19H22O6		>98%	1MG	5000	chiralix
CX64382-5MG	(±)-strigol	(3aR,5S,8bS,2'R)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one	51820-11-2	346.37	C19H22O6		>98%	5MG	18800	chiralix
CX88057-10MG	Nijmegen-1	(Z)-methyl2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate	159155-03-0	343.29	C17H13NO7		>98%	10MG	3600	chiralix
CX88057-50MG	Nijmegen-1	(Z)-methyl2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate	159155-03-0	343.29	C17H13NO7		>98%	50MG	11800	chiralix
CX42450-200MG	(S)-beta2-homophenylalanineHClsalt	(S)-3-amino-2-benzylpropanoicacidhydrochloride	1010806-95-7	215.68	C10H14ClNO2	(S)-beta2-hPhe-OH·HCl	>98%	200MG	4800	chiralix
CX42450-500MG	(S)-beta2-homophenylalanineHClsalt	(S)-3-amino-2-benzylpropanoicacidhydrochloride	1010806-95-7	215.68	C10H14ClNO2	(S)-beta2-hPhe-OH·HCl	>98%	500MG	9800	chiralix
CX42450-1G	(S)-beta2-homophenylalanineHClsalt	(S)-3-amino-2-benzylpropanoicacidhydrochloride	1010806-95-7	215.68	C10H14ClNO2	(S)-beta2-hPhe-OH·HCl	>98%	1G	16000	chiralix
CX35419-200MG	(S)-beta2-homovalineHClsalt	(S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(S)-beta2-hVal-OH·HCl	>98%	200MG	4800	chiralix
CX35419-500MG	(S)-beta2-homovalineHClsalt	(S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(S)-beta2-hVal-OH·HCl	>98%	500MG	9800	chiralix
CX35419-1G	(S)-beta2-homovalineHClsalt	(S)-2-(aminomethyl)-3-methylbutanoicacidhydrochloride	Notavailable	167.63	C6H14ClNO2	(S)-beta2-hVal-OH·HCl	>98%	1G	16000	chiralix
CX11583-200MG	(R)-beta2-homophenylalanineHClsalt	(R)-3-amino-2-benzylpropanoicacidhydrochloride	Notavailable	215.68	C10H14ClNO2	(R)-beta2-hPhe-OH·HCl	>98%	200MG	4800	chiralix
CX11583-500MG	(R)-beta2-homophenylalanineHClsalt	(R)-3-amino-2-benzylpropanoicacidhydrochloride	Notavailable	215.68	C10H14ClNO2	(R)-beta2-hPhe-OH·HCl	>98%	500MG	9800	chiralix
CX11583-1G	(R)-beta2-homophenylalanineHClsalt	(R)-3-amino-2-benzylpropanoicacidhydrochloride	Notavailable	215.68	C10H14ClNO2	(R)-beta2-hPhe-OH·HCl	>98%	1G	16000	chiralix
CX92224-200MG	(S)-beta2-homoleucineHClsalt	(S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(S)-beta2-hLeu-OH·HCl	>98%	200MG	4800	chiralix
CX92224-500MG	(S)-beta2-homoleucineHClsalt	(S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(S)-beta2-hLeu-OH·HCl	>98%	500MG	9800	chiralix
CX92224-1G	(S)-beta2-homoleucineHClsalt	(S)-2-(aminomethyl)-4-methylpentanoicacidhydrochloride	Notavailable	181.66	C7H16ClNO2	(S)-beta2-hLeu-OH·HCl	>98%	1G	16000	chiralix
CX81018-500MG	(S)-Fmoc-beta2-homoalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	203854-58-4	325.36	C19H19NO4	(S)-Fmoc-beta2-hAla-OH	>98%	500MG	11200	chiralix
CX81018-1G	(S)-Fmoc-beta2-homoalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	203854-58-4	325.36	C19H19NO4	(S)-Fmoc-beta2-hAla-OH	>98%	1G	18400	chiralix
CX85919-500MG	(R)-Fmoc-beta2-homoalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	Notavailable	325.36	C19H19NO4	(R)-Fmoc-beta2-hAla-OH	>98%	500MG	11200	chiralix
CX85919-1G	(R)-Fmoc-beta2-homoalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoicacid	Notavailable	325.36	C19H19NO4	(R)-Fmoc-beta2-hAla-OH	>98%	1G	18400	chiralix
CX98774-500MG	(R)-Fmoc-beta2-homoleucine	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	1018899-99-4	367.44	C22H25NO4	(R)-Fmoc-beta2-hLeu-OH	>98%	500MG	11200	chiralix
CX98774-1G	(R)-Fmoc-beta2-homoleucine	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	1018899-99-4	367.44	C22H25NO4	(R)-Fmoc-beta2-hLeu-OH	>98%	1G	18400	chiralix
CX33604-500MG	(R)-Fmoc-beta2-homovaline	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	Notavailable	353.41	C21H23NO4	(R)-Fmoc-beta2-hVal-OH	>98%	500MG	11200	chiralix
CX33604-1G	(R)-Fmoc-beta2-homovaline	(R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	Notavailable	353.41	C21H23NO4	(R)-Fmoc-beta2-hVal-OH	>98%	1G	18400	chiralix
CX82946-500MG	(S)-Fmoc-beta2-homophenylalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	203854-62-0	401.45	C25H23NO4	(S)-Fmoc-beta2-hPhe-OH	>98%	500MG	11200	chiralix
CX82946-1G	(S)-Fmoc-beta2-homophenylalanine	(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	203854-62-0	401.45	C25H23NO4	(S)-Fmoc-beta2-hPhe-OH	>98%	1G	18400	chiralix
CX86231-500MG	(S)-Fmoc-beta2-homovaline	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	203854-59-5	353.41	C21H23NO4	(S)-Fmoc-beta2-hVal-OH	>98%	500MG	11200	chiralix
CX86231-1G	(S)-Fmoc-beta2-homovaline	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoicacid	203854-59-5	353.41	C21H23NO4	(S)-Fmoc-beta2-hVal-OH	>98%	1G	18400	chiralix
CX15046-500MG	(R)-Fmoc-beta2-homophenylalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	828254-16-6	401.45	C25H23NO4	(R)-Fmoc-beta2-hPhe-OH	>98%	500MG	11200	chiralix
CX15046-1G	(R)-Fmoc-beta2-homophenylalanine	(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoicacid	828254-16-6	401.45	C25H23NO4	(R)-Fmoc-beta2-hPhe-OH	>98%	1G	18400	chiralix
CX30199-500MG	(S)-Fmoc-beta2-homoleucine	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	193887-45-5	367.44	C22H25NO4	(S)-Fmoc-beta2-hLeu-OH	>98%	500MG	11200	chiralix
CX30199-1G	(S)-Fmoc-beta2-homoleucine	(S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoicacid	193887-45-5	367.44	C22H25NO4	(S)-Fmoc-beta2-hLeu-OH	>98%	1G	18400	chiralix
CX20422-1ML	cereulide(50µg/mLinacetonitrile)	cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3(50µg/mLinacetonitrile)	Notavailable	1153.40	C57H96N6O18	cereulidestocksolution	>95%	1ML	5000	chiralix
CX87778-1ML	13C6-cereulide(20µg/mLinacetonitrile)	cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3(20µg/mLinacetonitrile)	Notavailable	1159.36	C5113C6H96N6O18	13C6-cereulidestocksolution	>95%	1ML	5000	chiralix
CX18112-1G	4-(azidomethyl)benzoicacid	4-(azidomethyl)benzoicacid	79584-03-5	177.16	C8H7N3O2		>98%	1G	3000	chiralix
CX18112-5G	4-(azidomethyl)benzoicacid	4-(azidomethyl)benzoicacid	79584-03-5	177.16	C8H7N3O2		>98%	5G	7400	chiralix
CX18112-10G	4-(azidomethyl)benzoicacid	4-(azidomethyl)benzoicacid	79584-03-5	177.16	C8H7N3O2		>98%	10G	13200	chiralix
CX95981-5G	2,2,2-trichloroethoxysulfonylchloride	2,2,2-trichloroethoxysulfonylchloride	764-09-0	247.91	C2H2Cl4O2S	chlorosulfuricacid2,2,2-trichloroethylester	>98%	5G	2200	chiralix
CX95981-10G	2,2,2-trichloroethoxysulfonylchloride	2,2,2-trichloroethoxysulfonylchloride	764-09-0	247.91	C2H2Cl4O2S	chlorosulfuricacid2,2,2-trichloroethylester	>98%	10G	4000	chiralix
CX95981-25G	2,2,2-trichloroethoxysulfonylchloride	2,2,2-trichloroethoxysulfonylchloride	764-09-0	247.91	C2H2Cl4O2S	chlorosulfuricacid2,2,2-trichloroethylester	>98%	25G	8400	chiralix
CX62483-1G	2-(azidomethyl)benzoicacid	2-(azidomethyl)benzoicacid	289712-57-8	177.16	C8H7N3O2		>98%	1G	4200	chiralix
CX62483-2G	2-(azidomethyl)benzoicacid	2-(azidomethyl)benzoicacid	289712-57-8	177.16	C8H7N3O2		>98%	2G	7600	chiralix
CX62483-5G	2-(azidomethyl)benzoicacid	2-(azidomethyl)benzoicacid	289712-57-8	177.16	C8H7N3O2		>98%	5G	16000	chiralix
CX80461-1G	3-(azidomethyl)benzoicacid	3-(azidomethyl)benzoicacid	905973-32-2	177.16	C8H7N3O2		>98%	1G	4200	chiralix
CX80461-2G	3-(azidomethyl)benzoicacid	3-(azidomethyl)benzoicacid	905973-32-2	177.16	C8H7N3O2		>98%	2G	7600	chiralix
CX80461-5G	3-(azidomethyl)benzoicacid	3-(azidomethyl)benzoicacid	905973-32-2	177.16	C8H7N3O2		>98%	5G	16000	chiralix
CX27597-1G	2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazoliumtriflate	2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-iumtrifluoromethanesulfonate	1185733-70-3	457.66	C8H10Cl3F3N2O6S2		>98%	1G	2600	chiralix
CX27597-5G	2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazoliumtriflate	2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-iumtrifluoromethanesulfonate	1185733-70-3	457.66	C8H10Cl3F3N2O6S2		>98%	5G	9800	chiralix
CX50506-10MG	TIS108	6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one	Notavailable	335.40	C20H21N3O2		>98%	10MG	3600	chiralix
CX50506-50MG	TIS108	6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one	Notavailable	335.40	C20H21N3O2		>98%	50MG	13800	chiralix
CX50506-100MG	TIS108	6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one	Notavailable	335.40	C20H21N3O2		>98%	100MG	23000	chiralix
CX95469-10MG	4-Brdebranone	5-(4-bromophenoxy)-3-methylfuran-2(5H)-one	1332863-94-1	269.09	C11H9BrO3	4BD	>98%	10MG	3000	chiralix
CX95469-50MG	4-Brdebranone	5-(4-bromophenoxy)-3-methylfuran-2(5H)-one	1332863-94-1	269.09	C11H9BrO3	4BD	>98%	50MG	11400	chiralix
CX95469-100MG	4-Brdebranone	5-(4-bromophenoxy)-3-methylfuran-2(5H)-one	1332863-94-1	269.09	C11H9BrO3	4BD	>98%	100MG	19600	chiralix
CX75854-10MG	4-CNdebranone	5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one	1332863-97-4	215.20	C12H9NO3		>98%	10MG	3000	chiralix
CX75854-50MG	4-CNdebranone	5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one	1332863-97-4	215.20	C12H9NO3		>98%	50MG	11400	chiralix
CX75854-100MG	4-CNdebranone	5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one	1332863-97-4	215.20	C12H9NO3		>98%	100MG	19600	chiralix
CX52612-10MG	Abamineoxalicacidsalt	(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate	Notavailable	463.45	C23H26FNO8		>98%	10MG	3000	chiralix
CX52612-50MG	Abamineoxalicacidsalt	(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate	Notavailable	463.45	C23H26FNO8		>98%	50MG	11400	chiralix
CX52612-100MG	Abamineoxalicacidsalt	(E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminiumcarboxyformate	Notavailable	463.45	C23H26FNO8		>98%	100MG	19600	chiralix
CX93797-10G	Fmoc-D-cyclohexylglycine	(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	198543-96-3	379.45	C23H25NO4	Fmoc-D-Chg-OH	>97%	10G	6000	chiralix
CX93797-25G	Fmoc-D-cyclohexylglycine	(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	198543-96-3	379.45	C23H25NO4	Fmoc-D-Chg-OH	>97%	25G	13000	chiralix
CX29693-10G	Fmoc-L-cyclohexylglycine	(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	161321-36-4	379.45	C23H25NO4	Fmoc-L-Chg-OH	>97%	10G	6000	chiralix
CX29693-25G	Fmoc-L-cyclohexylglycine	(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid	161321-36-4	379.45	C23H25NO4	Fmoc-L-Chg-OH	>97%	25G	13000	chiralix

公司主要产品：

1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。

2、N-BOC保护的氨基酸骨架类

3、N-CBZ 保护的氨基酸骨架类

4、N-FMOC 保护的氨基酸骨架类

5、AZIDO氨基酸骨架类

6、β²氨基酸骨架类

7、FMOC保护的β2氨基酸骨架类

8、CHROMOGENIC 及FLUOROGENIC氨基酸

9、氨基乙醇及其衍生产品

10、CEREULIDE & 13C6-CEREULIDE（致吐毒素及其衍生品）

11、STRIGOLACTONES & ANALOGUES（独脚金内酯及其类似物）

12、其它产品

更多产品请访问：http://www.chiralix.com/

世界*实验材料供应商Chiralix正式授权上海金山科研平台为其中国代理，Chiralix在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金山科研平台一直秉承为中国科研客户带来的产品，的服务，签约Chiralix就是为了给广大科研客户带来更加完善的产品和服务

Chiralix中国代理，Chiralix上海代理，Chiralix北京代理，Chiralix广东代理，Chiralix江苏代理Chiralix湖北代理,Chiralix天津,Chiralix黑龙江代理,Chiralix内蒙古代理,Chiralix吉林代理,Chiralix福建代理,Chiralix江苏代理,Chiralix浙江代理,Chiralix四川代理,

我们公司zui大优势是强大的采购，

1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，

2：货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，

3：提供加急服务，一般1-2周到货，超过时限加急费全免

4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.

5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大交大复旦，中山等100多所大学，ROCHE，阿斯利康，国药，fisher等500多家公司

6：我们还是santa,AdvancedBiotechnologiesInc;AthensResearch&Technology,bangs,BBInternational,crystalchem,dianova,FDNeurotechnologies,Inc.FormuMaxScientific,Inc;Genebridege;GlycotopeBiotechnologyGmbH;iduron;InnovativeResearchofAmerica；Ludger；neuroprobe;omicronbio;Polysciences;prospecbi;QA-BIO；quickzyme；RESEARCHDIETS,INC；sterlitech；sysy；TriLinkBioTechnologies,Inc；worthington-biochem;zyagen;......几十家国外公司授权代理

7：我们还从事invitrogen，qiagen;abcam;sigma;neb;roche;merck;rnd;BD;GE;pierce;BioLegend....等*批发

© 金山科研平台是专业的授权总代理区域代理经销平台。
© 如需询价，请加客服QQ：1749072012 、客服微信：jinshanbio，或发送邮件到1749072012@qq.com
© 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务，数据资源基于CC协议。
© 本文地址：https://16ao.com/thread-219166.htm
© Chiralix 2015，产品报价联系微信jinshanbio

特别声明：以上内容(如有图片亦包括在内)来源于授权厂家或网络，如有侵权，请联系删除，本平台不提供信息存储服务。

Notice: The content above (including the pictures if any)comes from authorized manufacturers or networks. In case of infringement, please contact to delete it. This platform does not provide information storage services.

产品询价需求提交